Geyser Brands (TSX.V: GYSR) announced key appointments to its leadership team recently, including the addition of Dr. Bin Huang to the company’s board of directors (http://cnw.fm/c6cFk). An article discussing the company reads, “Joining the board of directors is Dr. Bin Huang, a seasoned, life-sciences executive with experience in strategy and new business development, financing and public markets, corporate governance and operations management in North America and Asia. She most recently served as CEO of Emerald Health Therapeutics Inc. and has held senior-management roles in both startups and Fortune 500 corporations. Huang holds a PhD in plant cell biology from the University of East Anglia, UK, and an MBA from the University of Toronto, Canada. . . . ‘The board of directors are extremely pleased that Dr. Huang has accepted our offer to join our growing company,’ Brad Kersch, chairman of the board, stated in a news release. ‘Her depth of experience in life sciences and her leadership demonstrated in the corporate world, particularly in the cannabis industry, will provide unparalleled value and oversight to the company’s development.’”
To view the full article, visit http://cnw.fm/8Iz1N
About Geyser Brands Inc.
Geyser Brands builds health-based, hemp-CBD consumer products in the nutraceutical, cosmetics, food and beverage and pet sectors worldwide. R&D investment in NanoFusion, a proprietary all-natural nanotechnology, delivers topical, cream, beverages and baked goods, oil, and tincture formulations with superior bioavailability and water solubility. Geyser Brands owns a Health Canada licensed producer (“LP”) in Port Coquitlam, British Columbia, that holds cultivation and processing licenses and is anticipating its R&D and sales licenses. The company is exclusively focusing on leveraging these assets to provide the regulatory infrastructure for its global brands and distribution strategy, acquiring hemp- and plant-based brands and infusing them with new CBD product lines in jurisdictions where the therapeutic ingredient is legal. The company’s proprietary NanoFusion technology surrounds oils and solves for the insolubility of CBD. Geyser Brands will utilize both of its GM-licensed facilities in British Columbia for the manufacturing and international distribution of its hemp- and CBD-based products. For more information, visit the company’s website at www.GeyserBrands.com.
NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at http://cnw.fm/GYSR
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
